Menghan Du
Impact in
-
- CRISPR and Genetic Engineering
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- RNA modifications and cancer
- Advanced biosensing and bioanalysis techniques
- Genomics and Chromatin Dynamics
- Epigenetics and DNA Methylation
Papers in
-
- CRISPR and Genetic Engineering 4
- RNA and protein synthesis mechanisms 3
- Inflammasome and immune disorders 2
- Bioactive natural compounds 1
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- Nathaniel Jillette (4 shared papers)Albert W. Cheng (4 shared papers)Jacqueline Jufen Zhu (3 shared papers)Sheng Li (2 shared papers)Aziz Taghbalout (2 shared papers)Patricia A. Clow (1 shared paper)Lili Guo (1 shared paper)Lixia Zhang (1 shared paper)
- Journals
- Nature Communications (4 papers)Pharmaceuticals (1 paper)Journal of Magnetism and Magnetic Materials (1 paper)International Journal of Molecular Sciences (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Menghan Du
10 papers receiving 293 citations
Peers
Comparison fields: 5 of 58
- Aging 6
- Molecular Biology 222
- Biomaterials 35
- Business and International Management 5
- Pharmaceutical Science 9
Countries citing papers authored by Menghan Du
This map shows the geographic impact of Menghan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menghan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menghan Du more than expected).
Fields of papers citing papers by Menghan Du
This network shows the impact of papers produced by Menghan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menghan Du. The network helps show where Menghan Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Menghan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2022 | 58 | |
| 3 | 2019 | 52 | |
| 4 | 2019 | 40 | |
| 5 | 2019 | 25 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 0 |
About Menghan Du
Menghan Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 11 papers that have together received 295 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (3 papers), Inflammasome and immune disorders (2 papers), MicroRNA in disease regulation (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Bioactive natural compounds (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Intestinal and Peritoneal Adhesions (1 paper). The work is most often cited by research in Aging (6 citations), Molecular Biology (222 citations), Biomaterials (35 citations), Business and International Management (5 citations) and Pharmaceutical Science (9 citations). Menghan Du has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Nathaniel Jillette, Albert W. Cheng, Jacqueline Jufen Zhu, Sheng Li, Aziz Taghbalout, Patricia A. Clow, Lili Guo, Lixia Zhang, Qinlu Zhang and Le Ma. Their work appears in journals such as Nature Communications, Pharmaceuticals, Journal of Magnetism and Magnetic Materials, International Journal of Molecular Sciences and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.